Royce & Associates LP Purchases Shares of 137,200 CryoPort Inc (CYRX)

Royce & Associates LP purchased a new stake in CryoPort Inc (NASDAQ:CYRX) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 137,200 shares of the consumer goods maker’s stock, valued at approximately $1,351,000. Royce & Associates LP owned approximately 0.54% of CryoPort at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. EAM Investors LLC acquired a new stake in shares of CryoPort in the second quarter valued at about $552,000. Granite Investment Partners LLC acquired a new position in CryoPort during the third quarter worth approximately $535,000. Vanguard Group Inc. increased its position in CryoPort by 96.9% during the second quarter. Vanguard Group Inc. now owns 519,100 shares of the consumer goods maker’s stock worth $2,554,000 after buying an additional 255,519 shares during the last quarter. D.A. Davidson & CO. increased its position in CryoPort by 16.6% during the second quarter. D.A. Davidson & CO. now owns 137,000 shares of the consumer goods maker’s stock worth $674,000 after buying an additional 19,500 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in CryoPort during the third quarter worth approximately $118,000. Institutional investors own 18.10% of the company’s stock.

CryoPort Inc (CYRX) opened at $8.83 on Friday. CryoPort Inc has a 12-month low of $1.96 and a 12-month high of $10.40.

A number of equities analysts have weighed in on the company. Roth Capital assumed coverage on CryoPort in a research report on Thursday, November 30th. They set a “buy” rating and a $12.50 price target on the stock. Janney Montgomery Scott boosted their price target on CryoPort from $10.00 to $12.00 and gave the stock a “buy” rating in a research report on Tuesday, October 3rd. Cowen reissued an “outperform” rating and set a $11.00 price target (up previously from $7.50) on shares of CryoPort in a research report on Tuesday, September 12th. Finally, Needham & Company LLC boosted their price target on CryoPort from $8.50 to $10.00 and gave the stock a “buy” rating in a research report on Wednesday, August 30th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $33.50.

COPYRIGHT VIOLATION WARNING: “Royce & Associates LP Purchases Shares of 137,200 CryoPort Inc (CYRX)” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another site, it was copied illegally and reposted in violation of U.S. & international copyright laws. The correct version of this article can be accessed at https://www.com-unik.info/2017/12/23/royce-associates-lp-purchases-shares-of-137200-cryoport-inc-cyrx.html.

CryoPort Profile

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CryoPort Inc (NASDAQ:CYRX).

Institutional Ownership by Quarter for CryoPort (NASDAQ:CYRX)

What are top analysts saying about CryoPort? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CryoPort and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit